Renata Raises $25M in Series D Round - Orange County Business Journal

Renata Medical Raises Funds for Commercialization and Development of Pediatric Cardiovascular Technologies

August 19, 2026—Renata Medical, a privately held developer of pediatric cardiovascular technologies, announced the close of a $25 million Series D financing round. According to the company, proceeds from the financing will support expanded commercialization efforts in the United States for the company’s Minima stent system, as well as entrance into international markets; advancement of the company's pipeline of pediatric-specific congenital hear…

Renata Raises $25M in Series D Round - Orange County Business Journal

Renata Medical, a Newport Beach startup focused on improving treatment for children with congenital heart defects, today announced the closing of a $25 million Series D round. Proceeds from the round, led by healthcare investment firm Archimed, will support expanded U.S. commercialization of the company’s Mimina Stent System, an expandable heart valve stent specifically tailored for neonates, infants and young children. “Adoption of the Minima S…

Renata Medical Closes $25M Series D Financing Led by Global Healthcare Investment Firm ARCHIMED to Accelerate Commercialization and Development of Pediatric Cardiovascular Technologies

enata Medical, a privately held medical technology company dedicated to transforming care for children with congenital heart disease (CHD), today announced the close of a $25 million Series D financing round. The round was led by ARCHIMED, a global investment firm focused exclusively on healthcare, with participation from existing investors.